Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies
Geisse, John, Caro, Ivor, Lindholm, Jane, Golitz, Loren, Stampone, Patti, Owens, Mary
Published in Journal of the American Academy of Dermatology (01.05.2004)
Published in Journal of the American Academy of Dermatology (01.05.2004)
Get full text
Journal Article
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma
Sofen, Howard, MD, Gross, Kenneth G., MD, Goldberg, Leonard H., MD, FRCP, Sharata, Harry, MD, PhD, Hamilton, Tiffani K., MD, Egbert, Barbara, MD, Lyons, Benjamin, PhD, Hou, Jeannie, MD, Caro, Ivor, MD
Published in Journal of the American Academy of Dermatology (01.07.2015)
Published in Journal of the American Academy of Dermatology (01.07.2015)
Get full text
Journal Article
Gene Expression Profiling in BRAF -Mutated Melanoma Reveals Patient Subgroups with Poor Outcomes to Vemurafenib That May Be Overcome by Cobimetinib Plus Vemurafenib
Wongchenko, Matthew J, McArthur, Grant A, Dréno, Brigitte, Larkin, James, Ascierto, Paolo A, Sosman, Jeffrey, Andries, Luc, Kockx, Mark, Hurst, Stephen D, Caro, Ivor, Rooney, Isabelle, Hegde, Priti S, Molinero, Luciana, Yue, Huibin, Chang, Ilsung, Amler, Lukas, Yan, Yibing, Ribas, Antoni
Published in Clinical cancer research (01.09.2017)
Published in Clinical cancer research (01.09.2017)
Get full text
Journal Article
Subcutaneous efalizumab is not effective in the treatment of alopecia areata
Price, Vera H., MD, Hordinsky, Maria K., MD, Olsen, Elise A., MD, Roberts, Janet L., MD, Siegfried, Elaine C., MD, Rafal, Elyse S., MD, Korman, Neil J., MD, PhD, Altrabulsi, Basel, MD, Leung, Hoi M., PhD, Garovoy, Marvin R., MD, Caro, Ivor, MD, Whiting, David A., MD
Published in Journal of the American Academy of Dermatology (01.03.2008)
Published in Journal of the American Academy of Dermatology (01.03.2008)
Get full text
Journal Article
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
McArthur, Grant A, Prof, Chapman, Paul B, Prof, Robert, Caroline, MD, Larkin, James, MD, Haanen, John B, MD, Dummer, Reinhard, Prof, Ribas, Antoni, Prof, Hogg, David, Prof, Hamid, Omid, MD, Ascierto, Paolo A, MD, Garbe, Claus, Prof, Testori, Alessandro, MD, Maio, Michele, MD, Lorigan, Paul, MD, Lebbé, Celeste, Prof, Jouary, Thomas, MD, Schadendorf, Dirk, Prof, O'Day, Stephen J, MD, Kirkwood, John M., Prof, Eggermont, Alexander M, Prof, Dréno, Brigitte, Prof, Sosman, Jeffrey A, Prof, Flaherty, Keith T, MD, Yin, Ming, PhD, Caro, Ivor, MD, Cheng, Suzanne, PhD, Trunzer, Kerstin, PhD, Hauschild, Axel, Prof
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
Weiss, Glen J, Tibes, Raoul, Blaydorn, Lisa, Jameson, Gayle, Downhour, Molly, White, Erica, Caro, Ivor, Von Hoff, Daniel D
Published in Dermatology reports (01.12.2011)
Published in Dermatology reports (01.12.2011)
Get full text
Journal Article
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
McArthur, Grant A, Chapman, Paul B, Robert, Caroline, Larkin, James, Haanen, John B, Dummer, Reinhard, Ribas, Antoni, Hogg, David, Hamid, Omid, Ascierto, Paolo A, Garbe, Claus, Testori, Alessandro, Maio, Michele, Lorigan, Paul, Lebbé, Celeste, Jouary, Thomas, Schadendorf, Dirk, O'Day, Stephen J, Kirkwood, John M, Eggermont, Alexander M, Dréno, Brigitte, Sosman, Jeffrey A, Flaherty, Keith T, Yin, Ming, Caro, Ivor, Cheng, Suzanne, Trunzer, Kerstin, Hauschild, Axel
Published in The lancet oncology (01.03.2014)
Published in The lancet oncology (01.03.2014)
Get full text
Journal Article
Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib
Bhutani, Tina, Abrouk, Michael, Sima, Camelia S., Sadetsky, Natalia, Hou, Jeannie, Caro, Ivor, Chren, Mary-Margaret, Arron, Sarah T.
Published in Journal of the American Academy of Dermatology (01.10.2017)
Published in Journal of the American Academy of Dermatology (01.10.2017)
Get full text
Journal Article
Ocular Toxicity in BRAF Mutant Cutaneous Melanoma Patients Treated With Vemurafenib
Choe, Christina H, McArthur, Grant A, Caro, Ivor, Kempen, John H, Amaravadi, Ravi K
Published in American journal of ophthalmology (01.10.2014)
Published in American journal of ophthalmology (01.10.2014)
Get full text
Journal Article
Vismodegib Efficacy in Advanced Basal Cell Carcinoma Maintained with 8-Week Dose Interruptions: A Model-Based Evaluation
Chanu, Pascal, Musib, Luna, Wang, Xin, Cheeti, Sravanthi, Girish, Sandhya, Bruno, Rene, Lu, Tong, Reddy, Josina, Jin, Jin Y., Caro, Ivor
Published in Journal of investigative dermatology (01.04.2021)
Published in Journal of investigative dermatology (01.04.2021)
Get full text
Journal Article
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAFV600 wild-type melanoma progressing on prior anti–programmed death-1 therapy
Sandhu, Shahneen, Atkinson, Victoria, Cao, Maria González, Medina, Theresa, Rivas, Ainara Soria, Menzies, Alexander M., Caro, Ivor, Roberts, Louise, Song, Yuyao, Yan, Yibing, Guo, Yu, Xue, Cloris, Long, Georgina V.
Published in European journal of cancer (1990) (01.01.2023)
Published in European journal of cancer (1990) (01.01.2023)
Get full text
Journal Article
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
Ascierto, Paolo A, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Lewis, Karl, Protsenko, Svetlana, Pereira, Rodrigo P, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev, Zhukova, Natalia, Schachter, Jacob, Yan, Yibing, Caro, Ivor, Hertig, Christian, Xue, Cloris, Kusters, Lieke, McArthur, Grant A, Gutzmer, Ralf
Published in The lancet oncology (01.01.2023)
Published in The lancet oncology (01.01.2023)
Get full text
Journal Article
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAF V600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
Ascierto, Paolo A, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Lewis, Karl, Protsenko, Svetlana, Pereira, Rodrigo P, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev, Zhukova, Natalia, Schachter, Jacob, Yan, Yibing, Caro, Ivor, Hertig, Christian, Xue, Cloris, Kusters, Lieke, McArthur, Grant A, Gutzmer, Ralf
Published in The lancet oncology (01.01.2023)
Published in The lancet oncology (01.01.2023)
Get full text
Journal Article
Overall survival (OS) with first-line atezolizumab (A) or placebo (P) in combination with vemurafenib (V) and cobimetinib (C) in BRAF V600 mutation-positive advanced melanoma: Second interim OS analysis of the phase 3 IMspire150 study
McArthur, Grant A., Gutzmer, Ralf, Stroyakovskiy, Daniil, Gogas, Helen, Robert, Caroline, Protsenko, Svetlana, Pereira, Rodrigo Perez, Eigentler, Thomas, Rutkowski, Piotr, Demidov, Lev V., Zhukova, Natalia V., Schachter, Jacob, Yan, Yibing, Caro, Ivor, Hertig, Christian, Xue, Cloris, Kusters, Lieke, Ascierto, Paolo Antonio, Lewis, Karl D.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Effects of baseline lactate dehydrogenase (LDH), interferon gamma (IFN-g) expression, and tumor mutational burden (TMB) on treatment response to first-line atezolizumab (A) + vemurafenib (V) and cobimetinib (C) in BRAF V600 mutation–positive advanced melanoma
Robert, Caroline, Lewis, Karl D., Ascierto, Paolo Antonio, Munhoz, Rodrigo Ramella, Liszkay, Gabriella, de la Cruz-Merino, Luis, Olah, Judit, Queirolo, Paola, Mackiewicz, Jacek, Caro, Ivor, Shah, Kalpit, Forbes, Harper, Li, Haocheng, Hertig, Christian, Yan, Yibing, Mckenna, Edward Francis, Gutzmer, Ralf, McArthur, Grant A.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article